Viewing nowCombinationGlucitapoin Extended Release Tablet 100/1000 mg
Sitagliptin Hydrochloride Hydrate 113.37mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Keeps Biopharma Co., Ltd.

MFDS item code 202300608 · Approved 2023.02.17 · Insurance code 693202530
Improvement of glycemic control in patients with type 2 diabetes
This medication is used in combination with sitagliptin and metformin to assist in improving blood sugar control in patients with type 2 diabetes alongside dietary regulation and exercise therapy.
In antidiabetic therapy, the dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this medication should be taken with a meal once daily, preferably in the evening, with gradual dose escalation. Take 1 tablet of this medication 100/1000 mg extended-release tablets once daily. Patients taking this medication 50/500 mg extended-release tablets or 50/1000 mg extended-release tablets should take 2 tablets together once daily. 1. Patients not currently receiving metformin: For patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy, or for whom adequate blood glucose control cannot be achieved with sitagliptin monotherapy, the initial total daily dose of this medication is sitagliptin 100 mg and metformin 1000 mg. If adequate blood glucose control cannot be achieved with the initial dose, the dose may be gradually increased up to the maximum recommended daily dose of metformin 2000 mg to reduce gastrointestinal adverse reactions caused by metformin. 2. Patients receiving metformin: - For patients whose blood glucose is not adequately controlled with metformin monotherapy, the recommended initial total daily dose of this medication is sitagliptin 100 mg and the patient's current metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this medication may start at their current doses of sitagliptin and metformin. - Patients taking immediate-release tablets at a current metformin dose of 850 mg or 1000 mg twice daily may start with 2 tablets of this medication 50/1000 mg extended-release tablets once daily. 3. Patients whose blood glucose is not adequately controlled with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial total daily dose of this medication is sitagliptin 100 mg, and the initial metformin dose should be determined based on the patient's blood glucose level and current dose. To reduce gastrointestinal adverse reactions caused by metformin, increase the dose gradually. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Patients with renal impairment This medication may be used in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Treatment should not be initiated with this medication, because the starting dose of metformin is 500 mg or 850 mg once daily. The maximum recommended dose of metformin is 1000 mg daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this medication must be discontinued immediately.
This medication contains two components, sitagliptin and metformin, primarily used for blood sugar control in type 2 diabetes patients. Severe allergic reactions may occur when taking this medication, so if symptoms like rash, hives, or difficulty breathing appear, you must stop taking it immediately and consult a doctor. Pancreatitis, an inflammation of the pancreas, may rarely occur; if symptoms like abdominal pain, nausea, or vomiting appear, immediate medical attention is required. Patients with impaired kidney function, acute heart failure, dehydration, severe infections, etc., should not take this medication. Particularly in cases of reduced kidney function, administration should be discontinued. This drug can cause lactic acidosis, a rare but serious metabolic disturbance, so if symptoms like muscle pain, difficulty breathing, fatigue, or abdominal pain appear, inform your doctor immediately. During treatment, regular kidney function and blood tests should be conducted, as vitamin B12 levels may decrease, requiring periodic testing. Additionally, alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid alcohol while on this medication. Before surgery or tests using radiographic contrast agents, this medication should be discontinued for a period of time, and it should be resumed only after confirming normal kidney function post-examination. Since there is a risk of hypoglycemia, if taken with other blood sugar-lowering medications, blood sugar changes should be closely monitored, especially during irregular meals, intense exercise, or nutritional deficits. This medication is not recommended for use in pregnant or nursing women, or in children under 18, as safety has not been established. Finally, it is crucial to consult healthcare professionals immediately if there are any abnormal symptoms during the course of treatment to receive appropriate care.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, lactic acidosis, hypoglycemia, diarrhea, upper respiratory infection, headache, nausea, vomiting, abdominal pain, nasopharyngitis, peripheral edema, severe joint pain accompanied by disability, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, rash, urticaria, cutaneous vasculitis, acute renal failure, constipation, severe joint pain, bullous pemphigoid, elevated serum creatinine, anemia, elevated liver enzymes, acute renal failure, severe hypoglycemia, hypoglycemic syndrome, severe hypoglycemia, severe delayed hypoglycemia, hypoglycemic symptoms, hypoglycemic adverse reactions
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the medication safely for a long time.
Bright blue, oval, bilayer, convex extended-release film-coated tablets
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.37mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Keeps Biopharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.